Related Experiment Video
Updated: Jun 24, 2026
06:15
Murine Intrapulmonary Tracheal Transplantation: A Model for Investigating Obliterative Airway Disease After Lung Transplantation
Published on: November 10, 2023
Neuroendocrine proliferation after lung transplantation
Patrick O Myers1, Paola M Gasche-Soccal, John H Robert
1Division of Cardiovascular Surgery, Geneva University Hospital, Geneva, Switzerland. patrick.myers@hcuge.ch
Summary
Neuroendocrine tumors are rare after organ transplants. This study reports two new cases following lung transplantation, highlighting the need for further research into these uncommon post-transplant neoplasms.
Area of Science:
- Oncology
- Transplantation Medicine
- Pathology
Background:
- Neuroendocrine tumors (NETs) are rarely reported following solid-organ transplantation.
- The behavior and incidence of NETs in transplant recipients are not well understood.
Observation:
- This report details the first two cases of neuroendocrine proliferation and tumors diagnosed after lung transplantation.
- These cases involved the development of indolent, rare tumors, distinct from neuroendocrine carcinoma.
Findings:
- The occurrence of neuroendocrine tumors post-transplantation is exceptionally rare.
- The specific clinical behavior of these tumors in the context of immunosuppression and organ transplantation remains largely unknown.
Implications:
- These findings underscore the importance of monitoring for rare neoplastic complications after solid-organ transplantation.
- Further investigation is warranted to understand the pathogenesis and long-term outcomes of neuroendocrine tumors in transplant recipients.
